Immune tolerance induction (ITI) according to the Bonn protocol in haemophilia A patients with inhibitors using a plasma-derived VWF-containing factor VIII concentrate: two paediatric case reports

被引:0
|
作者
Lohse, J. [1 ]
Gehrisch, S. [1 ]
Escuriola-Ettingshausen, C. [2 ]
Kreuz, W. [2 ]
Knoefler, R. [1 ]
机构
[1] Univ Hosp Dresden, Dresden, Germany
[2] Johann Wolfgang Goethe Univ Hosp, Frankfurt, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1073 / 1074
页数:2
相关论文
共 33 条
  • [31] Successful Immune Tolerance Induction in Patients with Hemophilia A and Inhibitors Treated with a Plasma-Derived FVIII Product Containing von Willebrand Factor: A Large International, Multicentre, Retrospective Study
    Oldenburg, J.
    Santagostino, E.
    Jimenez-Yuste, V.
    Kurth, M.
    HAEMOPHILIA, 2012, 18 : 93 - 93
  • [32] Real-world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow-up retrospective analysis
    Carcao, Manuel
    Shapiro, Amy
    Hwang, Nina
    Pipe, Steven
    Ahuja, Sanjay
    Lieuw, Ken
    Staber, Janice M.
    Belletrutti, Mark
    Sun, Haowei Linda
    Ding, Hilda
    Wang, Michael
    Price, Victoria
    Steele, MacGregor
    Tsao, Elisa
    Feng, Jing
    Al-Khateeb, Zahra
    Dumont, Jennifer
    Jain, Nisha
    HAEMOPHILIA, 2021, 27 (01) : 19 - 25
  • [33] Long-Term Follow-up of Hemophilia a Patients Who Previously Showed Complete or Partial Success in Immune Tolerance Induction Therapy with a Single Plasma-Derived FVIII/VWF Product: Long-Term ITI Study
    Jimenez-Yuste, Victor
    Oldenburg, Johannes
    Rangarajan, Savita
    Peiro, Roser
    Santagostino, Elena
    BLOOD, 2015, 126 (23)